Home
>
National Drug Code (NDC)
>
LBel
LBel - 13537-028-02 - (Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide)
Drug Information of LBel
| Product NDC: | 13537-028 |
| Proprietary Name: | LBel |
| Non Proprietary Name: | Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Active Ingredient(s): | .075; .04; .1; .06; .01 g/g; g/g; g/g; g/g; g/g & nbsp; Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of LBel
| Product NDC: | 13537-028 |
| Labeler Name: | Ventura Corporation Ltd. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20110810 |
Package Information of LBel
| Package NDC: | 13537-028-02 |
| Package Description: | 1 BOTTLE in 1 CARTON (13537-028-02) > 5 g in 1 BOTTLE (13537-028-01) |
NDC Information of LBel
| NDC Code | 13537-028-02 |
| Proprietary Name | LBel |
| Package Description | 1 BOTTLE in 1 CARTON (13537-028-02) > 5 g in 1 BOTTLE (13537-028-01) |
| Product NDC | 13537-028 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate, Octisalate, Octocrylene, Oxybenzone, and Titanium dioxide |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20110810 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Ventura Corporation Ltd. |
| Substance Name | OCTINOXATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE; TITANIUM DIOXIDE |
| Strength Number | .075; .04; .1; .06; .01 |
| Strength Unit | g/g; g/g; g/g; g/g; g/g |
| Pharmaceutical Classes |
